Moderna says FDA will not complete review of RSV vaccine by May 12 deadline 0 10.05.2024 14:45 MarketWatch.com The FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a statement. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
